Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6500
-0.0500 (-2.94%)
NASDAQ · Last Trade: Jan 16th, 2:00 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors